Tissue Engineering Laboratory, Department of Mechanical Engineering, The University of Hong Kong, Pokfulam Road, Pokfulam, Hong Kong.
Department of Orthopaedics & Traumatology, Li ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
Sci Rep. 2019 Aug 28;9(1):12453. doi: 10.1038/s41598-019-47946-3.
The current study aims to evaluate collagen microencapsulation as an in vitro 3D culture platform for human osteoarthritic chondrocytes (hOACs), and to exemplify its feasibility in screening potential disease modifying factors. We first isolated and expanded hOACs from osteoarthritis (OA) cartilage samples harvested from multiple patients during total knee replacement (TKR) surgery. These cells were microencapsulated into collagen microspheres for subsequent 3D cultures. The change in chondrocyte phenotypes and OA phenotype was evaluated over time, using 2D monolayer culture and traditional 3D pellet culture as controls. The hOACs in the 3D collagen microsphere model resumed their in vivo phenotypes when compared to 2D monolayer. When compared with the 3D pellet model, the 3D hOAC-collagen microsphere model better recapitulated the OA phenotypes. We further demonstrated the responsiveness of the microencapsulated hOACs towards a number of external factors altering the chondrogenic phenotype, corroborating with previous studies. The hOAC encapsulated collagen microspheres better maintained the hOAC phenotype than the traditional 2D monolayer and 3D pellet cultures. The feasibility to use this hOAC-collagen microsphere in vitro model as a screening platform for disease-modifying agents has been demonstrated, contributing to future development of OA therapeutics.
本研究旨在评估胶原微胶囊作为体外 3D 培养人骨关节炎软骨细胞(hOAC)的平台,并举例说明其在筛选潜在疾病修饰因子中的可行性。我们首先从全膝关节置换术(TKR)手术中多位患者的骨关节炎(OA)软骨样本中分离和扩增 hOAC。将这些细胞微囊化为胶原微球,用于随后的 3D 培养。使用 2D 单层培养和传统的 3D 微球培养作为对照,随时间评估软骨细胞表型和 OA 表型的变化。与 2D 单层相比,3D 胶原微球模型中的 hOAC 恢复了其体内表型。与 3D 微球模型相比,3D hOAC-胶原微球模型更好地再现了 OA 表型。我们进一步证明了微囊化 hOAC 对许多改变软骨形成表型的外部因素的反应性,与之前的研究结果一致。与传统的 2D 单层和 3D 微球培养相比,胶原微囊化的 hOAC 更好地保持了 hOAC 表型。已经证明,使用这种 hOAC-胶原微球体外模型作为疾病修饰剂的筛选平台是可行的,这有助于 OA 治疗的未来发展。